US Stock MarketDetailed Quotes

ARTV Artiva Biotherapeutics

Watchlist
  • 11.300
  • +0.370+3.39%
Close Aug 29 16:00 ET
274.44MMarket Cap-8439P/E (TTM)

Artiva Biotherapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q1)Mar 31, 2022
(FY)Dec 31, 2021
(Q4)Dec 31, 2021
(Q1)Mar 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-16.33%-13.69M
-5.92%-15.09M
6.69%-47.43M
-11.76M
-47.38%-14.24M
-232.13%-50.83M
-213.96%-9.66M
-13.02%-15.3M
-84.53%-6.91M
8.48M
Net income from continuing operations
-58.13%-17.84M
16.47%-13.96M
51.15%-28.72M
---11.28M
-37.88%-16.72M
18.15%-58.79M
71.62%-12.12M
-299.23%-71.83M
-92.08%-11.39M
---42.72M
Operating gains losses
--2.35M
--268K
--707K
----
----
----
----
----
----
----
Depreciation and amortization
12.08%603K
1.56%587K
95.68%2.27M
--538K
246.11%578K
366.94%1.16M
421.88%167K
239.73%248K
540.91%141K
--32K
Other non cash items
----
----
----
----
----
----
----
6,773.74%18.55M
--0
--18.55M
Change In working capital
99.80%-7K
-4,812.50%-3.02M
-631.51%-28.28M
---3.46M
-93.11%64K
-111.57%-3.87M
-97.11%929K
666.70%33.41M
23.72%2.69M
--32.15M
-Change in receivables
116.91%262K
104.26%35K
-2,064.91%-1.23M
---1.55M
-9.89%-822K
87.82%-57K
-1,285.19%-748K
---468K
--146K
---54K
-Change in prepaid assets
-77.39%296K
-291.63%-936K
167.54%516K
--1.31M
72.14%-239K
-232.17%-764K
-167.29%-858K
60.07%-230K
719.35%768K
---321K
-Change in payables and accrued expense
53.74%-681K
-411.22%-2.19M
-114.63%-1.32M
---1.47M
-77.83%704K
-111.85%-615K
22.96%3.18M
16.68%5.19M
26.23%2.51M
--2.58M
-Change in other current assets
3.33%31K
-6.06%31K
214.88%139K
--30K
--33K
---121K
----
--0
----
----
-Change in other current liabilities
----
----
--0
----
----
--74K
----
----
----
----
-Change in other working capital
104.78%85K
-88.40%45K
-1,007.05%-26.38M
---1.78M
160.53%388K
-108.24%-2.38M
-102.14%-641K
11,514.46%28.92M
-1,106.85%-735K
--29.94M
Cash from discontinued investing activities
Operating cash flow
-16.33%-13.69M
-5.92%-15.09M
6.69%-47.43M
---11.76M
-47.38%-14.24M
-232.13%-50.83M
-213.96%-9.66M
-13.02%-15.3M
-84.53%-6.91M
--8.48M
Investing cash flow
Cash flow from continuing investing activities
106.44%1.35M
625.35%9.78M
-312.37%-25.98M
-20.95M
-209.30%-1.86M
-265.37%-6.3M
-1,208.70%-602K
-507.04%-1.72M
-364.32%-1.12M
-46K
Net PPE purchase and sale
20.14%-464K
99.03%-18K
48.28%-3.26M
---581K
-209.30%-1.86M
-265.37%-6.3M
-1,208.70%-602K
-507.04%-1.72M
-364.32%-1.12M
---46K
Net investment purchase and sale
108.90%1.81M
--9.8M
---22.72M
---20.37M
--0
--0
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
106.44%1.35M
625.35%9.78M
-312.37%-25.98M
---20.95M
-209.30%-1.86M
-265.37%-6.3M
-1,208.70%-602K
-507.04%-1.72M
-364.32%-1.12M
---46K
Financing cash flow
Cash flow from continuing financing activities
-16,260.00%-1.62M
0
2,029.67%24.39M
10K
96.07%-12K
-100.83%-1.26M
-100.20%-305K
308.49%152.75M
13.31%-241K
153.98M
Net issuance payments of debt
----
----
----
----
----
----
----
--0
--0
----
Net common stock issuance
--0
--0
-140.00%-12K
--0
---12K
---5K
----
--0
----
----
Net preferred stock issuance
----
----
----
----
----
----
--0
346.35%154.61M
200.00%1K
--154.62M
Proceeds from stock option exercised by employees
----
----
7,250.30%24.4M
----
----
89.71%332K
47.41%199K
--175K
--5K
--135K
Net other financing activities
----
----
----
----
----
21.74%-1.59M
34.63%-504K
-342.92%-2.03M
24.00%-247K
---771K
Cash from discontinued financing activities
Financing cash flow
-16,260.00%-1.62M
--0
2,029.67%24.39M
--10K
96.07%-12K
-100.83%-1.26M
-100.20%-305K
308.49%152.75M
13.31%-241K
--153.98M
Net cash flow
Beginning cash position
-44.08%48.46M
-47.69%53.76M
-36.23%102.78M
--86.66M
-36.23%102.78M
533.47%161.17M
533.47%161.17M
1,259.08%25.44M
470.40%169.43M
--25.44M
Current changes in cash
57.34%-13.95M
67.09%-5.3M
16.06%-49.01M
---32.71M
-52.46%-16.12M
-143.02%-58.39M
-106.51%-10.57M
475.84%135.73M
-93.92%-8.27M
--162.41M
End cash Position
-36.04%34.51M
-44.08%48.46M
-47.69%53.76M
--53.95M
-42.46%86.66M
-36.23%102.78M
-19.83%150.6M
533.47%161.17M
533.47%161.17M
--187.86M
Free cash flow
-14.61%-14.15M
6.22%-15.1M
11.27%-50.69M
---12.35M
-56.88%-16.11M
-235.49%-57.13M
-221.72%-10.27M
-23.17%-17.03M
-101.46%-8.02M
--8.43M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q1)Mar 31, 2022(FY)Dec 31, 2021(Q4)Dec 31, 2021(Q1)Mar 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -16.33%-13.69M-5.92%-15.09M6.69%-47.43M-11.76M-47.38%-14.24M-232.13%-50.83M-213.96%-9.66M-13.02%-15.3M-84.53%-6.91M8.48M
Net income from continuing operations -58.13%-17.84M16.47%-13.96M51.15%-28.72M---11.28M-37.88%-16.72M18.15%-58.79M71.62%-12.12M-299.23%-71.83M-92.08%-11.39M---42.72M
Operating gains losses --2.35M--268K--707K----------------------------
Depreciation and amortization 12.08%603K1.56%587K95.68%2.27M--538K246.11%578K366.94%1.16M421.88%167K239.73%248K540.91%141K--32K
Other non cash items ----------------------------6,773.74%18.55M--0--18.55M
Change In working capital 99.80%-7K-4,812.50%-3.02M-631.51%-28.28M---3.46M-93.11%64K-111.57%-3.87M-97.11%929K666.70%33.41M23.72%2.69M--32.15M
-Change in receivables 116.91%262K104.26%35K-2,064.91%-1.23M---1.55M-9.89%-822K87.82%-57K-1,285.19%-748K---468K--146K---54K
-Change in prepaid assets -77.39%296K-291.63%-936K167.54%516K--1.31M72.14%-239K-232.17%-764K-167.29%-858K60.07%-230K719.35%768K---321K
-Change in payables and accrued expense 53.74%-681K-411.22%-2.19M-114.63%-1.32M---1.47M-77.83%704K-111.85%-615K22.96%3.18M16.68%5.19M26.23%2.51M--2.58M
-Change in other current assets 3.33%31K-6.06%31K214.88%139K--30K--33K---121K------0--------
-Change in other current liabilities ----------0----------74K----------------
-Change in other working capital 104.78%85K-88.40%45K-1,007.05%-26.38M---1.78M160.53%388K-108.24%-2.38M-102.14%-641K11,514.46%28.92M-1,106.85%-735K--29.94M
Cash from discontinued investing activities
Operating cash flow -16.33%-13.69M-5.92%-15.09M6.69%-47.43M---11.76M-47.38%-14.24M-232.13%-50.83M-213.96%-9.66M-13.02%-15.3M-84.53%-6.91M--8.48M
Investing cash flow
Cash flow from continuing investing activities 106.44%1.35M625.35%9.78M-312.37%-25.98M-20.95M-209.30%-1.86M-265.37%-6.3M-1,208.70%-602K-507.04%-1.72M-364.32%-1.12M-46K
Net PPE purchase and sale 20.14%-464K99.03%-18K48.28%-3.26M---581K-209.30%-1.86M-265.37%-6.3M-1,208.70%-602K-507.04%-1.72M-364.32%-1.12M---46K
Net investment purchase and sale 108.90%1.81M--9.8M---22.72M---20.37M--0--0----------------
Cash from discontinued investing activities
Investing cash flow 106.44%1.35M625.35%9.78M-312.37%-25.98M---20.95M-209.30%-1.86M-265.37%-6.3M-1,208.70%-602K-507.04%-1.72M-364.32%-1.12M---46K
Financing cash flow
Cash flow from continuing financing activities -16,260.00%-1.62M02,029.67%24.39M10K96.07%-12K-100.83%-1.26M-100.20%-305K308.49%152.75M13.31%-241K153.98M
Net issuance payments of debt ------------------------------0--0----
Net common stock issuance --0--0-140.00%-12K--0---12K---5K------0--------
Net preferred stock issuance --------------------------0346.35%154.61M200.00%1K--154.62M
Proceeds from stock option exercised by employees --------7,250.30%24.4M--------89.71%332K47.41%199K--175K--5K--135K
Net other financing activities --------------------21.74%-1.59M34.63%-504K-342.92%-2.03M24.00%-247K---771K
Cash from discontinued financing activities
Financing cash flow -16,260.00%-1.62M--02,029.67%24.39M--10K96.07%-12K-100.83%-1.26M-100.20%-305K308.49%152.75M13.31%-241K--153.98M
Net cash flow
Beginning cash position -44.08%48.46M-47.69%53.76M-36.23%102.78M--86.66M-36.23%102.78M533.47%161.17M533.47%161.17M1,259.08%25.44M470.40%169.43M--25.44M
Current changes in cash 57.34%-13.95M67.09%-5.3M16.06%-49.01M---32.71M-52.46%-16.12M-143.02%-58.39M-106.51%-10.57M475.84%135.73M-93.92%-8.27M--162.41M
End cash Position -36.04%34.51M-44.08%48.46M-47.69%53.76M--53.95M-42.46%86.66M-36.23%102.78M-19.83%150.6M533.47%161.17M533.47%161.17M--187.86M
Free cash flow -14.61%-14.15M6.22%-15.1M11.27%-50.69M---12.35M-56.88%-16.11M-235.49%-57.13M-221.72%-10.27M-23.17%-17.03M-101.46%-8.02M--8.43M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg